A Progressive Loss of phosphoSer 138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling 

Baharani A, Wei Z, Roesler WJ, Mousseau DD.

The Nuclear Lamina: Protein Accumulation and Disease

Almendariz-Palacios C, Gillespie ZE, Janzen M, Martinez V, Bridger JM, Harkness TA, Mousseau DD, Eskiw CH.

Still Living Better through Chemistry: An Update on Caloric Restriction and Caloric Restriction Mimetics as Tools to Promote Health and Lifespan

Almendariz-Palacios C, Mousseau DD, Eskiw CH, Gillespie ZE.

The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide
implicated in Alzheimer disease progression

Quartey M, Nyarko JNK, Maley JM, Barnes JR, Bolanos MAC, Heistad RM, Knudsen KJ, Pennington PR, Buttigieg J, Carvalho CED, Leary SC, Parsons PM, Mousseau DD.

Age- and sex-dependent profiles of APP fragments and key secretases align with changes in despair-like behavior and cognition in young APPSwe/lnd mice

Quartey M, Nyarko JNK, Pennington PR, Heistad RM, Chaharyn BM, Wei Z, Bainbridge D, Baker GB, Mousseau DD

Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Nyarko, JNK, Quartey M, Baker GB, Mousseau DD.

Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex

Quartey M, Nyarko, JNK, Pennington PR, Heistad RM, Klassen P, Baker GB, Mousseau DD.

Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples

Nyarko, JNK, Quartey M, Heistad RM, Pennington PR, Poon LJ, Knudsen KJ, Allonby O, El Zawily AM, Freywald GR, Baker GB, Mousseau DD.

Profiles of b-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE e4 Status: Impact for Risk and Progression of Alzheimer Disease

Nyarko, JNK, Quartey M, Pennington PR, Heistad RM, Dea D, Poirier J, Baker GB, Mousseau DD.

Brain sample donor summary table

The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.

Moraros J, Nwankwo C, Patten SB, Mousseau DD.

Depress Anxiety. 2017 Mar;34(3):217-226. doi: 10.1002/da.22584. Epub 2016 Dec 28.

Cunningham CE, Li S, Vizeacoumar FS, Bhanumathy KK, Lee JS, Parameswaran S, Furber L, Abuhussein O, Paul JM, McDonald M, Templeton SD, Shukla H, El Zawily AM, Boyd F, Alli N, Mousseau DD, Geyer R, Bonham K, Anderson DH, Yan J, Yu-Lee LY, Weaver BA, Uppalapati M, Ruppin E, Sablina A, Freywald A, Vizeacoumar FJ.

Oncotarget. 2016 Sep 20;7(38):61544-61561. doi: 10.18632/oncotarget.11399.

Paul JM, Toosi B, Vizeacoumar FS, Bhanumathy KK, Li Y, Gerger C, El Zawily A, Freywald T, Anderson DH, Mousseau D, Kanthan R, Zhang Z, Vizeacoumar FJ, Freywald A.

Oncotarget. 2016 Aug 2;7(31):50027-50042. doi: 10.18632/oncotarget.10569.

Ahmed KA, Wang L, Griebel P, Mousseau DD, Xiang J.

J Leukoc Biol. 2015 Sep;98(3):313-8. doi: 10.1189/jlb.2HI0215-049RR. Epub 2015 May 19.

Reflections on Saskatchewan innovations in neuroscience

Baker G, Dyck E, Mousseau DD.

Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity

Cao X, Rui L, Pennington PR, Chlan-Fourney J, Jiang Z, Wei Z, Li X, Edmondson DE, Mousseau DD

Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid B-peptide in rats

Shang C, Xiao Duan D, Hong Ma R, Ying Shen J, Lian Li H, Wei Ma Z, Luo Y, Wang L, Hua Qi Z, Wang Q, Zhi Wang J, Wei Z, Mousseau DD, Wang L, Liu G.

The increased density of p38 mitogen-activated protein kinase-immunoreactive microglia in the sensorimotor cortex of aged TgCRND8 mice is associated predominantly with smaller dense-core amyloid plaques

Chlan-Fourney J, Zhao T, Walz W, Mousseau DD.

Survival of patients with incident dementia who had a pre-existing psychiatric disorder: a population-based 7-Year follow-up study

Meng X, D'Arcy C, Tempier R, Kou C, Morgan D, Mousseau DD.

Recent developments in the Regulation of Monoamine Oxidase From and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys] Function?

Mousseau DD, Baker GB.

Letter to the editor

Mousseau DD.

Alzheimer disease-related presenilin-1 cariants exert distinct effects on monoamine oxidase-A activity in vitro

Pennington PR, Wei Z, Rui L, Doig JA, Graham B, Kuski K, Gabriel GG, Mousseau DD.

The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line

Satram-Maharaj T, Nyarko JNK, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.

The nuclear localization of 3'-phosphoinositide-dependent kinase-1 is dependent on its association with the protein tyrosine phosphatase SHP-1

Sephton CF, Zhang D, Lehmann TM, Pennington PR, Scheid MP, Mousseau DD.

An update on amine oxidase inhibitors: Multifaceted drugs

Sook Song M, Matveychuk D, MacKenzie EM, Duchcherer M, Mousseau DD, Baker GB.

Trace Amines

Tomlinson S, Mousseau DD, Naker GN, Radomski AD.

Haloperidol disrupts Akt signaling to reveal a phophorylation-dependent regulation of pro-apoptotic Bcl-Xs function

Wei Z, Qi J, Dai Y, Bowen WD, Mousseau DD.

Monoamine Oxidase-A Physically Interacts with Presenilin-1(M146V) in the Mouse Cortex

Wei Z, Gabriel GG, Rui L, Cao X, Pennington PR, Chlan-Fourney J, Nazarali AJ, Baker GB, Mousseau DD.

Folate/vitamin-B12 Prevents Chronic Hyperhomocysteinemia-Induced Tau Hyperphosphorylation and Memory Deficits in Aged Rats

Wei W, Hua Liu Y, Zhang CE, Wang Q, Wei Z, Mousseau DD, Zhi Wang J, Tian Q, Ping Liu G